U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381114) titled 'A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-m... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381036) titled 'Comparison of Nebulized Ketamine With Nebulized Magnesium Sulfate for the Prevention of Post... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07382232) titled 'Isometric Stability vs. Isotonic Mobility for Chronic LBP' on Jan. 25. Brief Summary: Backg... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381868) titled 'Social Media Psychosocial Support Group in Reducing Alcohol Consumption' on Dec. 17, 2025. ... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07382479) titled 'NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery' ... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381270) titled 'Using Simulation-based Team Training to Improve Psychological Safety and Relational Coordina... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381777) titled 'XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemorad... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07380984) titled 'PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL' on Jan. 24. Brief Sum... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381738) titled 'Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders' on Ja... Read More
U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07382063) titled 'A Prospective, Single-blind, Randomized, Controlled, Single-center Study' on Jan. 26. Brief... Read More